VectivBio Holding AG Performance
| VECTDelisted Stock | USD 16.85 0.00 0.00% |
The entity has a beta of -1.24, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning VectivBio Holding are expected to decrease by larger amounts. On the other hand, during market turmoil, VectivBio Holding is expected to outperform it. VectivBio Holding right now has a risk of 0.0%. Please validate VectivBio Holding total risk alpha, as well as the relationship between the potential upside and kurtosis , to decide if VectivBio Holding will be following its existing price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days VectivBio Holding AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, VectivBio Holding is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Begin Period Cash Flow | 102.7 M |
VectivBio |
VectivBio Holding Relative Risk vs. Return Landscape
If you would invest 1,685 in VectivBio Holding AG on September 20, 2024 and sell it today you would earn a total of 0.00 from holding VectivBio Holding AG or generate 0.0% return on investment over 90 days. VectivBio Holding AG is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than VectivBio, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
VectivBio Holding Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for VectivBio Holding's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as VectivBio Holding AG, and traders can use it to determine the average amount a VectivBio Holding's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| VECT |
Based on monthly moving average VectivBio Holding is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of VectivBio Holding by adding VectivBio Holding to a well-diversified portfolio.
VectivBio Holding Fundamentals Growth
VectivBio Stock prices reflect investors' perceptions of the future prospects and financial health of VectivBio Holding, and VectivBio Holding fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on VectivBio Stock performance.
| Return On Equity | -0.57 | |||
| Return On Asset | -0.26 | |||
| Operating Margin | (2.95) % | |||
| Current Valuation | 846.2 M | |||
| Shares Outstanding | 62.81 M | |||
| Price To Book | 3.62 X | |||
| Price To Sales | 21.08 X | |||
| Revenue | 27.34 M | |||
| EBITDA | (79.85 M) | |||
| Cash And Equivalents | 142.14 M | |||
| Cash Per Share | 3.09 X | |||
| Total Debt | 10.46 M | |||
| Debt To Equity | 0 % | |||
| Book Value Per Share | 3.40 X | |||
| Cash Flow From Operations | (56.26 M) | |||
| Earnings Per Share | (2.10) X | |||
| Total Asset | 252.6 M | |||
| Retained Earnings | (207.76 M) | |||
About VectivBio Holding Performance
Assessing VectivBio Holding's fundamental ratios provides investors with valuable insights into VectivBio Holding's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the VectivBio Holding is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for treatments of severe rare conditions. The company was incorporated in 2019 and is headquartered in Basel, Switzerland. VectivBio Holding is traded on NASDAQ Exchange in the United States.Things to note about VectivBio Holding performance evaluation
Checking the ongoing alerts about VectivBio Holding for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for VectivBio Holding help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| VectivBio Holding is not yet fully synchronised with the market data | |
| VectivBio Holding has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 27.34 M. Net Loss for the year was (93.73 M) with profit before overhead, payroll, taxes, and interest of 27.34 M. | |
| VectivBio Holding AG currently holds about 142.14 M in cash with (56.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.09. | |
| Over 84.0% of the company outstanding shares are owned by institutional investors |
- Analyzing VectivBio Holding's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether VectivBio Holding's stock is overvalued or undervalued compared to its peers.
- Examining VectivBio Holding's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating VectivBio Holding's management team can have a significant impact on its success or failure. Reviewing the track record and experience of VectivBio Holding's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of VectivBio Holding's stock. These opinions can provide insight into VectivBio Holding's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in VectivBio Stock
If you are still planning to invest in VectivBio Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VectivBio Holding's history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |